AASLD2019（ボストン）に参加しました
2019-11-12
2019年11月8～12日にボストンで行われたAASLD 2019（米国肝臓病学会）に当教室から附属病院の中島淳主任教授、斉藤聡診療教授，日暮琢磨医師、結束貴臣医師、本多靖医師、岩城慶大医師が参加しました。
下記のように，中島主任教授と海外の先生方との多くの共同研究が発表されました．結束貴臣医師、本多靖医師、岩城慶大医師はポスターセッションにて発表を行いました。
学会では，他国・他施設の先生方との交流があり，活発な議論が交わされました．11月のボストンは非常に寒冷な気候でしたが，町自体は治安も落ち着いており過ごしやすく，学会を楽しむことができました。
このような貴重な機会を与えていただき感謝申し上げます。
2019年11月8日～12日 AASLD(ボストン)の発表リスト
-
Filaz Aslam,Sofia Mouchti,Andrea Dennis,Matt Kelly,Atsushi Nakajima，kento Imajo:Non-Invasive Imaging Modalities for Assessment of Fibrosis,Inflammation and Steatosis in a Japanese NASH Population. AASLD(Annual Meeting of the Amereican Association for the Study of Liver Diseases) The Liver Meeting,USA(Boston),November 10 2019.
-
Wei Jie Jonathan Lee, Xiang Xuan Eunice Tan, Wah Keong Chan, Sombat Treeprasertsuk, George Boon Bee Goh, Jian‐Gao Fan, Myeong Jun Song, Phunchai Charatcharoenwitthaya, Ajay K. Duseja, Kento Imajo, Atsushi Nakajima, Yosuke Seki, Kazunori Kasama, Satoru Kakizaki, Laurentius A. Lesmana, Khek Yu Ho, Khean Lee Goh, Vincent Wai‐Sun Wong, Yock Young Dan: Characterizing and Predicting Non‐Alcoholic Steatohepatitis (NASH) and Advanced Fibrosis in Non Obese Non‐Alcoholic Fatty Liver Disease (NAFLD) in Asia ‐ the Goasia Initiative (Oral 36). AASLD(Annual Meeting of the Amereican Association for the Study of Liver Diseases) The Liver Meeting,USA(Boston),November 11 2019.
-
Rohit Loomba, Naim Alkhouri, Keyur Patel, Jie Zhang, Bryan J McColgan, Stephen Djedjos, Robert P Myers, Michael Middleton, Zachary D Goodman, Kris V. Kowdley, Vincent Wai‐Sun Wong, Stephen A Harrison, Zobair M. Younossi, Eric J. Lawitz, Atsushi Nakajima, Mazen Noureddin: Validation of Cutoffs for Controlled Attenuation Parameter (CAP) with MRI‐Proton Density Fat Fraction (PDFF) as a Reference Standard in Subjects with Nonalcoholic Steatohepatitis (NASH) Across Multiple Randomized, Controlled Trials (Poster 1727).AASLD(Annual Meeting of the Amereican Association for the Study of Liver Diseases) The Liver Meeting,USA(Boston),November 11 2019.
-
Rohit Loomba, Naim Alkhouri, Mazen Noureddin, Jie Zhang, Bryan J McColgan, Stephen Djedjos, Robert P Myers, Michael Middleton, Zachary D Goodman, Kris V. Kowdley, Atsushi Nakajima, Stephen A Harrison, Zobair M. Younossi, Eric J. Lawitz, Vincent Wai‐Sun Wong, Keyur Patel:Validation of the Diagnostic Accuracy of Magnetic Resonance Elastography (MRE) for the Detection of Advanced Fibrosis due to Nash Across Multiple Phase 2 and 3 Clinical Trials(Poster 1728). AASLD(Annual Meeting of the Amereican Association for the Study of Liver Diseases) The Liver Meeting,USA(Boston),November 11 2019.
-
Takaomi Kessoku ,Takashi Kobayashi, Michihiro Iwaki,Anna Ozaki, Kento Imajo, Yasushi Honda,Takuma Higurashi,Yuji Ogawa,Masato Yoneda,Haruki Usuda, Koichiro Wada,Yousuke Oikawa,Yoshiki Tanaka,Shunji Nakajima,Satoru Saito, Atsushi Nakajima: Effect Of Cholestyramine on Mice Model of Nonalcoholic Steatohepatitis with Increased Gut Permeability (Poster 2200). AASLD(Annual Meeting of the Amereican Association for the Study of Liver Diseases) The Liver Meeting,USA(Boston),November 11 2019.
-
Michihiro Iwaki,Takaomi Kessoku,Annna Ozaki,Takashi Kobayashi,Yasushi Honada,Yuji Ogwa,Kento Imajo,Masato Yoneda,Satoru Saito,Atsushi Nakajima:Profiles of clinical feaures and gut microbiomes in non-obese NAFLD (Poster 2308).AASLD(Annual Meeting of the Amereican Association for the Study of Liver Diseases) The Liver Meeting,USA(Boston),November 11 2019.
-
Yasushi Honda,Takashi Kobayashi,Takaomi Kessoku,Yuji Ogawa,Kento Imajo,Masato Yoneda,Satoru Saito,Atsushi Nakajima: SGL5213, A Novel Sodium‐Glucose Cotransporter 1 (SGLT1) Inhibitor, Has A Therapeutic Effect On Nonalcoholic Fatty Liver Disease In Mice (Psoter 2215). AASLD(Annual Meeting of the Amereican Association for the Study of Liver Diseases) The Liver Meeting,USA(Boston Hynes Convention Centaer,Hall B),November 11 2019.
-
Kathryn Jean Lucas, Patricia Lopez, Eric J. Lawitz, Aasim Sheikh, Diego Aizenberg, Stanley Hsia, George Boon Bee Goh, John M. Vierling, Juan Pablo Frias, Judith White, Yuichiro Eguchi, Donald Lazas, Guy Neff, Masato Yoneda, Salvador Augustin, Won Kim, Juergen Loeffler, Felicity Ann Schaefer, Sophie Lamle, Miljen Martic, Clifford Brass，Arun Sanyal：LO4: Tropifexor, a highly potent fxr agonist, produces robust and dose-dependent reductions in hepatic fat and serum alanine aminotransferase in patients with fibrotic NASH after 12 weeks of therapy: flight-fxr part c interim results (Late-Bresking Abstract Oral Session Ⅰ)．AASLD(Annual Meeting of the Amereican Association for the Study of Liver Diseases) The Liver Meeting,USA(Boston Hynes Convention Center,Auditorium),November 11 2019.
